By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Apceth GmbH  

Max-Lebsche-Platz 30

  D-81377  M√ľnchen  Germany
Phone: 49-0-89-7009608 - 0 Fax: 49-0-89-7009608 - 79


SEARCH JOBS


Industry
Suppliers






Company News
Apceth GmbH 's Ground-Breaking First-In-Man, First-In-Class Clinical Trial In Oncology With Genetically Modified Mesenchymal Stem Cells Is Now Enrolling 1/23/2014 10:36:54 AM
Apceth GmbH Names Dr Stefanos Theoharis Chief Business Officer 9/5/2013 9:47:16 AM
As the First Biopharmaceutical Company Worldwide, Apceth GmbH Receives Approval for a Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells for the Treatment of Cancer 6/13/2013 9:03:54 AM
Apceth GmbH Received the Second Round of Funding for Its Innovative Stem Cell-Based Cancer Therapeutic as Part of the m4 Initiative of the Munich Biotech Cluster 2/4/2013 2:00:09 PM
Apceth GmbH and Indivumed GmbH to Develop Biomarker Platform for Targeted Cellular Therapies 2/22/2012 8:45:20 AM
Apceth GmbH und Co. KG Received Extended Manufacturer's Licence for Somatic Cell Therapeutics at the Ottobrunn Site 10/31/2011 9:33:14 AM
//-->